Rapid and accurate detection of SARS-CoV-2 mutations using a Cas12a-based sensing platform
Changsheng He,Cailing Lin,Guosheng Mo,Binbin Xi,Dongchao Huang,Yanbin Wan,Feng Chen,Yufeng Liang,Qingxia Zuo,Wanqing Xu,Dongyan Feng,Guanting Zhang,Liya Han,Changwen Ke,Hongli Du,Lizhen Huang,An′an Li
DOI: https://doi.org/10.1016/j.bios.2021.113857
IF: 12.545
2022-02-01
Biosensors and Bioelectronics
Abstract:The increasing prevalence of SARS-CoV-2 variants with spike mutations has raised concerns owing to higher transmission rates, disease severity, and escape from neutralizing antibodies. Rapid and accurate detection of SARS-CoV-2 variants provides crucial information concerning the outbreaks of SARS-CoV-2 variants and possible lines of transmission. This information is vital for infection prevention and control. We used a Cas12a-based RT-PCR combined with CRISPR on-site rapid detection system (RT-CORDS) platform to detect the key mutations in SARS-CoV-2 variants, such as 69/70 deletion, N501Y, and D614G. We used type-specific CRISPR RNAs (crRNAs) to identify wild-type (crRNA-W) and mutant (crRNA-M) sequences of SARS-CoV-2. We successfully differentiated mutant variants from wild-type SARS-CoV-2 with a sensitivity of 10<sup>-17</sup> M (approximately 6 copies/μL). The assay took just 10 min with the Cas12a/crRNA reaction after a simple RT-PCR using a fluorescence reporting system. In addition, a sensitivity of 10<sup>-16</sup> M could be achieved when lateral flow strips were used as readouts. The accuracy of RT-CORDS for SARS-CoV-2 variant detection was 100% consistent with the sequencing data. In conclusion, using the RT-CORDS platform, we accurately, sensitively, specifically, and rapidly detected SARS-CoV-2 variants. This method may be used in clinical diagnosis.
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology